Impact of aging on immune function in the pathogenesis of pulmonary diseases: potential for therapeutic targets

被引:2
|
作者
Shaikh, Sadiya Bi [1 ]
Goracci, Chiara [1 ,2 ]
Tjitropranoto, Ariel [1 ]
Rahman, Irfan [1 ,3 ]
机构
[1] Univ Rochester, Dept Environm Med, Med Ctr, Rochester, NY 14642 USA
[2] Univ Siena, Dept Mol & Dev Med, Siena, Italy
[3] Univ Rochester, Med Ctr, Sch Med & Dent, 601 Elmwood Ave, Rochester, NY 14642 USA
基金
美国国家卫生研究院;
关键词
Aging; Immunity; COPD; IPF; Lymphocytes; Cytokines; Cellular senescence; CELLULAR SENESCENCE; T-CELL; MONOCLONAL-ANTIBODY; BONE-MARROW; AGED MICE; LUNG; COPD; INFECTION; RESPONSES; ASTHMA;
D O I
10.1080/17476348.2023.2205127
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
IntroductionSeveral immunological alterations that occur during pulmonary diseases often mimic alterations observed in the aged lung. From the molecular perspective, pulmonary diseases and aging partake in familiar mechanisms associated with significant dysregulation of the immune systems. Here, we summarized the findings of how aging alters immunity to respiratory conditions to identify age-impacted pathways and mechanisms that contribute to the development of pulmonary diseases,Areas coveredThe current review examines the impact of age-related molecular alterations in the aged immune system during various lung diseases, such as COPD, IPF, Asthma, and alongside many others that could possibly improve on current therapeutic interventions. Moreover, our increased understanding of this phenomenon may play a primary role in shaping immunomodulatory strategies to boost outcomes in the elderly. Here, the authors present new insights into the context of lung-related diseases and describe the alterations in the functioning of immune cells during various pulmonary conditions altered with age.Expert opinionThe expert opinion provided the concepts on how aging alters immunity during pulmonary conditions, and suggests the associated mechanisms during the development of lung diseases. As a result, it becomes important to comprehend the complex mechanism of aging in the immune lung system.
引用
收藏
页码:351 / 364
页数:14
相关论文
共 50 条
  • [1] Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets
    Long, Hai
    Wang, Xin
    Chen, Yongjian
    Wang, Ling
    Zhao, Ming
    Lu, Qianjin
    CANCER LETTERS, 2018, 428 : 90 - 103
  • [2] The role of immune semaphorins in the pathogenesis of multiple sclerosis: Potential therapeutic targets
    Lotfi, Ramin
    Kalmarzi, Rasoul Nasiri
    Rajabinejad, Misagh
    Hasani, Sabah
    Zamani, Fatemeh
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 95
  • [3] The pathogenesis and potential therapeutic targets in sepsis
    Zhang, Wendan
    Jiang, Honghong
    Wu, Gaosong
    Huang, Pengli
    Wang, Haonan
    An, Huazhasng
    Liu, Sanhong
    Zhang, Weidong
    MEDCOMM, 2023, 4 (06):
  • [4] The Pathogenesis of Sepsis and Potential Therapeutic Targets
    Huang, Min
    Cai, Shaoli
    Su, Jingqian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
  • [5] Metabolic dysregulation in myelodysplastic neoplasm: impact on pathogenesis and potential therapeutic targets
    Zhou, Hao
    Xiang, Wenqiong
    Zhou, Guangyu
    Rodrigues-Lima, Fernando
    Guidez, Fabien
    Wang, Li
    MEDICAL ONCOLOGY, 2024, 42 (01)
  • [6] Neutrophils in liver diseases: pathogenesis and therapeutic targets
    Liu, Kai
    Wang, Fu-Sheng
    Xu, Ruonan
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (01) : 38 - 44
  • [7] Neutrophils in liver diseases: pathogenesis and therapeutic targets
    Kai Liu
    Fu-Sheng Wang
    Ruonan Xu
    Cellular & Molecular Immunology, 2021, 18 : 38 - 44
  • [8] Exosomes in brain diseases: Pathogenesis and therapeutic targets
    Si, Qingying
    Wu, Linlin
    Pang, Deshui
    Jiang, Pei
    MEDCOMM, 2023, 4 (03):
  • [9] Molecular pathogenesis and therapeutic targets of lysosomal diseases
    Tsuji, Daisuke
    Itoh, Kohji
    SEIKAGAKU, 2007, 79 (07): : 678 - 682
  • [10] Endothelial-to-mesenchymal transition: Pathogenesis and therapeutic targets for chronic pulmonary and vascular diseases
    Lu, Xuexin
    Gong, Jiannan
    Dennery, Phyllis A.
    Yao, Hongwei
    BIOCHEMICAL PHARMACOLOGY, 2019, 168 : 100 - 107